VAERS Explorer
Back to explore

Report #2862021

Received Sep 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
IL
Recovered
Unknown
Vaccinated
Sep 14, 2025
Onset
Sep 26, 2025
Days to onset
12
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1——
HPV9HPV (GARDASIL 9)MERCK & CO. INC.2Y010802—

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

no adverse event; inappropriate schedule; This spontaneous report was received from an Other health professional and refers to a 31-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 14-Sep-2025, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant Injection, dose number 1, (lot # and expiration date were not reported). On 26-Sep-2025, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant Injection (lot #Y010802, expiration date: 01-Jan-2027), dose number 2 (Inappropriate schedule of vaccine administered). No adverse event was reported.